Incidence, Risk Factors and Fetomaternal Outcome in Abruptio Placenta
Incidence, Risk Factors and Fetomaternal Outcome in Abruptio Placenta
Incidence, Risk Factors and Fetomaternal Outcome in Abruptio Placenta
11(02), 1163-1166
RESEARCH ARTICLE
INCIDENCE, RISK FACTORS AND FETOMATERNAL OUTCOME IN ABRUPTIO PLACENTA
Dr. Yenugudhati Ramya Satya Pavani Devi and Dr. Vaddadi Adi Lakshmi
……………………………………………………………………………………………………....
Manuscript Info Abstract
……………………. ………………………………………………………………
Manuscript History Abruptio placenta is defined as placental detachment before and during
Received: 31 December 2022 delivery.It remains a major cause of maternal and perinatal morbidity
Final Accepted: 31 January 2023 and mortality in developing countries.Over 50% of all perinatal deaths
Published: February 2023 attributed to abruptio placenta are accompanied by premature
delivery.In addition it accounts for 20-25% of antepartum
hemorrhage,increased risk of DIC,maternal shock ,renal
failure,PPH,and maternal death.This study aimed to determine the
incidence ,risk factors and fetomaternal outcome in abruptio placenta.
Methods:-
1. The retrospective observational study was carried out at Andhra medical
college,kinggeorgehospital,visakhapatnam has 6400 deliveries per year.
2. The study was carried out for a period of one year from july 2021 to june 2022.
3. The study population included all cases presenting with antepartum hemorrhage to department of OBG during
study period.
4. Subjects selected for the study were all cases diagnosed as having abruptio placenta.
5. All other causes of APH like placenta previa and extraplacental causes were excluded.
6. All study subjects underwent a complete obsteterical clinical workup including history,general physical
examination,abdominal and pelvic examination,laboratory tests and imaging were performed.
7. Patients were managed according to maternal and fetal condition
1163
Corresponding Author:- Dr.Yenugudhati Ramya Satya Pavani Devi
ISSN: 2320-5407 Int. J. Adv. Res. 11(02), 1163-1166
Results:-
Total cases during study period are 80
1) Age
Age No. Of cases(80) Percentage
<20yrs 8 10%
20-25 28 35%
26-30 30 37.5%
>30yrs 14 17.5%
1. Most of the abruptio cases are between 26 to 30 yrs
2. Next m.c age group is 20-25yrs
3. Least incidence is <20yrs
2) Parity
Parity No. Of cases Perecentage
Primi 16 20%
nd
2 gravida 22 27.5%
3) Risk Factors
Risk factors No.of cases Percentage
PIH 14 17.5%
PPROM 11 13.75%
Diabetes 12 15%
Postcs 8 10%
Hydramnios 11 13.75%
Unexplained 8 10%
1164
ISSN: 2320-5407 Int. J. Adv. Res. 11(02), 1163-1166
4) Maternal Complications
PPH 15 18.75%
AKI 12 15%
DIC 5 6.25%
Hysterectomy 3 3.75%
Shock 5 6.25%
Mortality 2 2.5%
Table shows pregnant women with abruptio placenta were at higher risk of developing complications like
PPH,AKI,DIC,shocketc
Normal 50 62.5%
Caesarean 30 37.5%
No. Of cases 20 12 13
6) Fetal Outcome
Fetus No.of cases Perecentage
Conclusion:-
1. Abruptio placenta is associated with high rate of maternal and fetal morbidity,because of this the conditions
predisposing it should be carefully evaluated in order to reduce occurrence of placental abruption.
2. Antenatal care which identifies risk factors like PIH plays an important role in decreasing incidence of abruptio
placenta amd improving maternal and fetal outcome.
3. Regular antenatal checkups,anemiacorrection,early diagnosis and identification of gestational hypertension
wouldprevent maternal and perinatal morbidity and mortality.
References:-
1. Workalemahu T, Enquobahrie DA, Gelaye B, Thornton TA, Tekola-Ayele F, Sanchez SE, et al. Abruptio
placentae risk and genetic variations in mitochondrial biogenesis and oxidative phosphorylation: replication of a
candidate gene association study. Am J Obstet Gynecol. 2018;219(6):617-e1.
1165
ISSN: 2320-5407 Int. J. Adv. Res. 11(02), 1163-1166
2. Sylvester HC, Stringer M. Placental abruption leading to hysterectomy. Case Reports. 2017;2017.
3. Miller C, Grynspan D, Gaudet L, Ferretti E, Lawrence S, Moretti F, et al. Maternal and neonatal characteristics
of a Canadian urban cohort receiving treatment for opioid use disorder during pregnancy. J Develop Orig
Health Dis. 2019;10(1):132-7.
4. Ananth CV, Berkowitz GS, Savitz DA, Lapinski RH. Placental abruption and adverse perinatal outcomes.
JAMA. 1999;282(17):1646-51.
1166